FOLH1 and prostate cancer: More recently, extensive development of PET tracers for prostate-specific membrane antigen (PSMA), which is widely expressed in prostate cancer, has produced agents of superb selectivity for detection of lesions; these are likely to play a major role in PET imaging of prostate cancer [188,189].